Evofem Biosciences Inc. (EVFM) shares are trading at lower $2.26 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $7.50 and the low is $1.91. Over the last 52 weeks, EVFM is down -63.25% while the S&P 500 is up 15.47%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, EVFM reported a profit of $39000.0. Evofem Biosciences Inc. also saw revenues decrease to $0.28 million. In addition, EVFM has free cash flow of -$66.58 million as of 09-2020. The company’s EBITDA came in at -$26.1 million which compares well with its peers.
FREE CONFIDENTIAL REPORT
3 Stocks Set To Soar By January 1st, 2021
You have Successfully Subscribed!
EVFM Return on Equity (ROE) is -365.00%, and its Return on Assets is -157.10%. All told, it is clear that, EVFM needs to be on your watchlist.
Find out when EVFM reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. EVFM has a short ratio of 1.89 and outstanding shares of 81.21M.
EVFM has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.92 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.93. Evofem Biosciences Inc. EVFM also noted assets of $112.33 million at the end of the last quarter. Investors should also keep an eye on sector updates as EVFM has historically followed its peers on positive news.
All told, Evofem Biosciences Inc. EVFM has strung together solid data and demonstrated underlying fundamentals. At its current valuation, EVFM represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Evofem Biosciences Inc. EVFM is now commanding a market cap of 183.72M and a float of 79.95M. EVFM is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of EVFM stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in EVFM, either long or short, and we have not been compensated for this article.